Literature DB >> 7627342

Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors.

M Murakami1, K Miyashita, S Kakizaki, S Saito, M Yamada, T Iriuchijima, T Takeuchi, M Mori.   

Abstract

Human thyrotropin (TSH) receptors were expressed in Chinese hamster ovary (CHO) cells using eukaryotic expression plasmid pCXN2, which contains beta-actin promoter. We measured cAMP stimulation in CHO cells expressing human TSH receptors (CHO-hTSH-R cells) by immunoglobulin G (IgG) of patients with Graves' disease and Hashimoto's thyroiditis, and compared the results with a conventional thyroid-stimulating antibody (TS-Ab) assay using porcine thyroid cells and a TSH-binding inhibiting immunoglobulin (TBII) assay. Nineteen untreated patients with Graves' disease, including a case who developed hyperthyroidism after interferon -alpha therapy for chronic hepatitis C, and 13 treated patients with Graves' disease, 10 patients with Hashimoto's thyroiditis and 8 control subjects were studied. In 19 untreated patients with Graves' disease, 17 patients showed positive CHO-hTSH-R cell stimulation, 11 patients showed positive porcine thyroid cell stimulation and 15 patients showed positive TBII. All the untreated patients showed positive results in at least one assay. Although significantly positive correlations were observed among CHO-hTSH-R cell stimulation, porcine thyroid cell stimulation and TBII activities, the IgG of several patients showed significant discrepancy in the assay results. In a patient with interferon-induced hyperthyroidism only CHO-hTSH-R cell stimulation was positive, while porcine thyroid cell stimulation and TBII were negative. After the treatment with propylthiouracil for 6 months, CHO-hTSH-R cell stimulation became negative. The IgG of patients with Hashimoto's thyroiditis did not show significant stimulation of CHO-hTSH-R cells. These results suggest that the CHO-hTSH-R cell stimulation assay is clinically useful for the diagnosis and follow-up of patients with Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627342     DOI: 10.1530/eje.0.1330080

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  4 in total

Review 1.  Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice.

Authors:  Joshua M Estrada; Danielle Soldin; Timothy M Buckey; Kenneth D Burman; Offie P Soldin
Journal:  Thyroid       Date:  2013-12-13       Impact factor: 6.568

2.  Na(+)-dependent glucose transporter SGLT1 is localized in the apical plasma membrane upon completion of tight junction formation in MDCK cells.

Authors:  T Suzuki; K Fujikura; K Takata
Journal:  Histochem Cell Biol       Date:  1996-12       Impact factor: 4.304

3.  Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems.

Authors:  W Akamatsu; H J Okano; N Osumi; T Inoue; S Nakamura; S Sakakibara; M Miura; N Matsuo; R B Darnell; H Okano
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

4.  Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics.

Authors:  Bei H Morrison; Joseph A Bauer; Jiadi Hu; Ronald W Grane; Aylin M Ozdemir; Mamta Chawla-Sarkar; Bendi Gong; Alex Almasan; Dhananjaya V Kalvakolanu; Daniel J Lindner
Journal:  Oncogene       Date:  2002-03-14       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.